Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Soleno Therapeutics, Inc. (SLNO) had Return on Investments of 4.18% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$190.41M |
|
$20.48M |
|
$2.70M |
|
$187.71M |
|
$180.99M |
|
$9.41M |
|
$11.48M |
|
$20.89M |
|
$20.89M |
|
$20.89M |
|
$20.89M |
|
$20.89M |
|
$20.89M |
|
$9.41M |
|
$11.47M |
|
50.82M |
|
52.38M |
|
$0.40 |
|
$0.39 |
|
| Balance Sheet Financials | |
$355.81M |
|
$0.18M |
|
$208.02M |
|
$563.83M |
|
$61.36M |
|
$49.86M |
|
$52.35M |
|
$113.72M |
|
$450.12M |
|
$445.25M |
|
$450.12M |
|
52.29M |
|
| Cash Flow Statement Financials | |
$46.80M |
|
$-201.78M |
|
$137.16M |
|
$87.93M |
|
$70.11M |
|
$-17.82M |
|
$45.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.80 |
|
-- |
|
-- |
|
0.10 |
|
0.11 |
|
98.58% |
|
4.94% |
|
4.94% |
|
6.02% |
|
10.97% |
|
10.75% |
|
$46.73M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
0.18 |
|
6.75 |
|
54.07 |
|
4.64% |
|
4.69% |
|
3.71% |
|
|
Return on Investments |
4.18% |
$8.61 |
|
$0.89 |
|
$0.89 |
|